TACR1 and neurodegenerative disease: Another study also showed that L-NAT, an antagonist of the neurokinin 1 receptor (NK-1R) known to disrupt the binding of Substance P (SP) to NK-1R, played a protective role on neurodegenerative diseases (Sirianni et al., 2015).